Article Details

UK Stocks: AstraZeneca's (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial

Retrieved on: 2024-06-25 15:33:17

Tags for this article:

Click the tags to see associated articles and topics

UK Stocks: AstraZeneca's (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial. View article details on hiswai:

Excerpt

In top news on UK stocks, AstraZeneca PLC (GB:AZN) released disappointing results for its cancer drug, Imfinzi, in an advanced lung cancer tria...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up